Current European practice in pediatric myeloablative conditioning

Area of Science:

• Pediatric Hematology
• Oncology
• Transplantation Medicine

Background:

• Myeloablative conditioning is crucial for pediatric hematopoietic stem cell transplantation.
• Fractionated total body irradiation (fTBI) is a common conditioning method for pediatric ALL, offering anti-leukemic effects but causing long-term sequelae.
• Chemotherapy-only regimens are feasible and used for other pediatric indications like AML and severe aplastic anemia.

Purpose of the Study:

• To review current conditioning strategies in pediatric hematopoietic stem cell transplantation.
• To discuss the role of fractionated TBI and chemotherapy-only regimens.
• To highlight emerging factors influencing conditioning regimen modification.

Main Methods:

• Review of existing literature on conditioning regimens in pediatric transplantation.
• Analysis of data on the efficacy and toxicity of different conditioning approaches.
• Discussion of novel factors impacting conditioning strategies.

Main Results:

• Fractionated TBI remains a cornerstone for pediatric ALL, despite known long-term effects.
• Chemotherapy-only regimens are established for various pediatric hematologic malignancies and disorders.
• Factors such as pre-transplant disease burden, HLA typing, and haploidentical transplantation are influencing current practices.

Conclusions:

• Conditioning regimens in pediatric transplantation are evolving.
• The choice of conditioning depends on the specific indication, disease status, and patient factors.
• Further research is needed to optimize conditioning for improved outcomes and reduced toxicity.